[The differentiation and sensitivity of enterococci to chemotherapeutics in urinary tract infections].
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D001437:Bacteriuria / Q000382:microbiology; D003470:Culture Media; D013293:Enterococcus faecalis / Q000145:classification / Q000187:drug effects / Q000254:growth & development; D006801:Humans; D007202:Indicators and Reagents; D008826:Microbial Sensitivity Tests; D009268:Nalidixic Acid; D009582:Nitrofurantoin / Q000494:pharmacology; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D013291:Streptococcus / Q000145:classification* / Q000187:drug effects* / Q000254:growth & development / Q000302:isolation & purification; D014552:Urinary Tract Infections / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D003470:Culture Media; D007202:Indicators and Reagents; D010406:Penicillins; D009268:Nalidixic Acid; D000667:Ampicillin; D009582:Nitrofurantoin
Zur Differenzierung und chemotherapeutischen Empfindlichkeit von Enterokokken bei Harnwegsinfektionen.